- Home
- ISTR vs PBYI Comparison
ISTR vs PBYI Comparison
Compare ISTR & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISTR
- PBYI
- Stock Information
- Founded
- ISTR 2006
- PBYI 2010
- Country
- ISTR United States
- PBYI United States
- Employees
- ISTR N/A
- PBYI N/A
- Industry
- ISTR Major Banks
- PBYI Biotechnology: Pharmaceutical Preparations
- Sector
- ISTR Finance
- PBYI Health Care
- Exchange
- ISTR Nasdaq
- PBYI Nasdaq
- Market Cap
- ISTR 189.6M
- PBYI 167.3M
- IPO Year
- ISTR 2014
- PBYI N/A
- Fundamental
- Price
- ISTR $18.31
- PBYI $3.24
- Analyst Decision
- ISTR Buy
- PBYI Strong Buy
- Analyst Count
- ISTR 1
- PBYI 1
- Target Price
- ISTR $22.00
- PBYI $7.00
- AVG Volume (30 Days)
- ISTR 19.4K
- PBYI 347.1K
- Earning Date
- ISTR 07-21-2025
- PBYI 07-31-2025
- Dividend Yield
- ISTR 2.30%
- PBYI N/A
- EPS Growth
- ISTR 22.25
- PBYI 143.51
- EPS
- ISTR 2.19
- PBYI 0.77
- Revenue
- ISTR $88,885,000.00
- PBYI $232,709,000.00
- Revenue This Year
- ISTR $2.04
- PBYI N/A
- Revenue Next Year
- ISTR $9.79
- PBYI N/A
- P/E Ratio
- ISTR $8.34
- PBYI $4.40
- Revenue Growth
- ISTR 6.35
- PBYI 2.68
- 52 Week Low
- ISTR $14.60
- PBYI $2.23
- 52 Week High
- ISTR $24.81
- PBYI $4.13
- Technical
- Relative Strength Index (RSI)
- ISTR 43.66
- PBYI 50.17
- Support Level
- ISTR $17.89
- PBYI $3.38
- Resistance Level
- ISTR $19.67
- PBYI $3.70
- Average True Range (ATR)
- ISTR 0.46
- PBYI 0.18
- MACD
- ISTR -0.13
- PBYI -0.03
- Stochastic Oscillator
- ISTR 23.60
- PBYI 35.82
About ISTR Investar Holding Corporation
Investar Holding Corp is a U.S.-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashiers' checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.